Animal Drug User Fee Act; Public Meeting; Request for Comments
Details
The document's own metadata, straight from the source system.
- Title
- Animal Drug User Fee Act; Public Meeting; Request for Comments
- Posted
- Apr 17, 2026
- Comment period
- Apr 17, 2026 – Dec 2, 2027
- FR Doc
- 2026-07498
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Choose up to five.
| Organization | Adufa reauthorization | Modernization of animal drug review |
|---|
2 organization-typed comments could not be identified.
Campaigns
Organized form-letter drives, separated from organic one-off comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jul 7, 2026Comment from Wyman Rosalie SSupportIndividual
The commenter supports the proposed action by advocating for the FDA to seek authority from Congress to collect data on antibiotic use in large livestock facilities. They argue that this data is necessary to combat antibiotic resistance and to eventually prohibit the overuse of antibiotics on factory farms.
Read comment → - Jul 6, 2026Comment from Barbour MichelleSupportIndividual
The commenter supports the proposed action by advocating for stricter regulations on veterinary drug use. They specifically call for the FDA to request that Congress prohibit antibiotic use longer than 21 days and ban routine preventive use in healthy animals to combat antibiotic resistance.
Read comment → - Jul 4, 2026Comment from Cason KellySupportIndividual
The commenter supports the proposed action by advocating for stricter regulations on veterinary drug use. They specifically call for the FDA to request that Congress prohibit antibiotic use longer than 21 days and ban routine preventive use in healthy animals to combat antibiotic resistance.
Read comment → - Jun 28, 2026Comment from Sewright KathleenSupportIndividual
The commenter supports the reauthorization of the Animal Drug User Fee Act (ADUFA) but argues that the FDA should seek greater authority from Congress to address antibiotic resistance and public health risks. They specifically advocate for the ability to require label changes for animal drugs when specific uses pose a risk.
Read comment → - Jun 28, 2026Comment from Russell SandraSupportIndividual
The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.
Read comment → - Jun 28, 2026Comment from Serody LucilleSupportIndividual
The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.
Read comment → - Jun 27, 2026Comment from Millikin ErinSupportIndividual
The commenter supports the proposed action by advocating for stricter regulations on veterinary drug use. They specifically call for the FDA to request that Congress prohibit antibiotic use longer than 21 days and ban routine preventive use in healthy animals to combat antibiotic resistance.
Read comment → - Jun 26, 2026Comment from de Graaf RiniSupportIndividual
The commenter supports the proposed action by advocating for the FDA to seek authority from Congress to collect data on antibiotic use in large livestock facilities. They argue that this data is necessary to combat antibiotic resistance and to eventually prohibit the overuse of antibiotics on factory farms.
Read comment → - Jun 26, 2026Comment from Johnson HeatherSupportIndividual
The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.
Read comment → - Jun 24, 2026Comment from Miller MeredithSupportIndividual
The commenter supports the reauthorization of the Animal Drug User Fee Act (ADUFA) but argues that the FDA should seek greater authority from Congress to address antibiotic resistance and public health risks. They specifically advocate for the ability to require label changes for animal drugs when specific uses pose a risk.
Read comment →